The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2017
Filed:
Oct. 12, 2007
Ali Rezai, Shaker Heights, OH (US);
Nicholas Schiff, New York, NY (US);
Scott Kokones, Cleveland, OH (US);
Andre Machado, Beachwood, OH (US);
Sierra Farris, Kirkland, WA (US);
Ali Rezai, Shaker Heights, OH (US);
Nicholas Schiff, New York, NY (US);
Scott Kokones, Cleveland, OH (US);
Andre Machado, Beachwood, OH (US);
Sierra Farris, Kirkland, WA (US);
Intelect Medical, Inc., Cleveland, OH (US);
The Cleveland Clinic Foundation, Cleveland, OH (US);
Cornell Research Foundation, Inc., Ithaca, NY (US);
Abstract
A system for treating medical conditions by neuromodulation of one or more target sites in the nervous system. In certain embodiments, at least one of the target sites is the medial thalamic region, including the intralaminar nucleus and the adjacent white and grey matter. In certain embodiments, where there is more than one target site, the other target sites is elsewhere in the nervous system, including the globus pallidus interna, subthalamic nucleus, corpus callosum, cerebellum, cerebral cortex (including the premotor cortex, motor cortex, and sensory cortex), ventral striatum, lateral thalamus, substantia nigra, and pedunculopontine nuclei. The medical conditions include movement disorders or improvement of movement function, stroke, neuropsychiatric or neuropsychologic disorders, neurodevelopmental disorders, and pain. Methods for treating medical conditions by neuromodulation of the intralaminar nuclei either alone or in combination with another target site(s) is also provided.